And more than one in ten over the age of 70 would meet the criteria for drugs to slow early stages of the disease.

The MM+M editorial team was heartened by the progress made treating Alzheimer’s disease, the case of KJ Muldoon and ...

In today’s Pharmaceutical Executive Daily, the FDA approves a new LDL-lowering therapy, Sanofi announces two strategic deals ...

Swedish researchers, who monitored the eating habits of over 27,000 middle-aged adults, said those who regularly ate cheese, were less likely to have a diagnosis.

A new study presents robust evidence on the role of lysophosphatidylcholines (LPCs) in the onset of Alzheimer’s disease. Researchers discovered that LPCs—compounds that transport a variety of healthy ...

First Study to Use a pTau217 Blood Test to Detect Alzheimer's Disease Early and at ScaleCARLSBAD, Calif., /PRNewswire/ -- ALZpath, Inc., a ...

New research, published in Nature, has provided the first ever population-based data on the frequency of Alzheimer's disease ...

New Alzheimer's drug Leqembi offers hope to Oklahoma couple as they celebrate 50 years of marriage and fight against the ...

One in ten people over the age of 70, an unexpectedly high proportion, meet the criteria to be offered drug treatment for ...

A pioneering study indicates that Alzheimer’s disease is considerably more widespread among individuals over 85 than ...

Alzheimer’s Disease research is advancing with developments like Roche’s new biomarker blood test. Yet 98% of AD clinical ...